Letellier Pharma SRL
Letellier Pharma reported total assets of €3.04m at the end of the 2025 financial year (annual accounts filed with the NBB on 12 May 2026).
By total assets for 2025, Letellier Pharma ranks among the 5,000 largest of the 50,410 companies in its sector (NACE 7020) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of Letellier Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +38 % Total assets +1 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Letellier Pharma's annual accounts
Filed annual accounts
- Year ended 30 Sep 2025filed on 12 May 2026
- Year ended 30 Sep 2024filed on 15 Apr 2025
- Year ended 30 Sep 2023filed on 11 Mar 2024
- Year ended 30 Sep 2022filed on 24 Mar 2023
- Year ended 30 Sep 2021filed on 15 Apr 2022
Letellier Pharma's financial analysis
- Solvency49.0%sector median: 58.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Letellier Pharma
Letellier Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0554.748.443
- VAT number
- BE0554748443
- Peppol
- Registered · 0208:0554748443 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 25 Jun 2014
- Registered office
- 3080 Tervuren
- Latest accounts
- 2025 · filed on 12 May 2026
- Activity
- Business and other management consultancy activities (NACE 70200)
Letellier Pharma (SRL) has been based in Tervuren since 2014, active in: business and other management consultancy activities. For 2025, it reports a net profit of 139,809 € and equity of €1.49m; its revenue is not published. Its solvency stands at 49.0%, below the median of its sector (58.4%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Letellier Pharma
Companies in the same business, of comparable size and area, outside its group.
- Fiabilis Consulting Group Belgium Business and other management consultancy activities Brussels · balance sheet €3.04m
- VEVA Business and other management consultancy activities Aalst · balance sheet €3.04m
- Sataaya Business and other management consultancy activities Ghent · balance sheet €3.04m
- DGM Invest Business and other management consultancy activities Anderlecht · balance sheet €3.04m
- Hillen Franky Business and other management consultancy activities Zoersel · balance sheet €3.35m
- Jatmaco Business and other management consultancy activities Deinze · balance sheet €3.04m
- Domus Consulting Business and other management consultancy activities Saint-Josse-ten-Noode · balance sheet €3.05m
- CACTUS MGMT Group Business and other management consultancy activities Ixelles · balance sheet €3.03m
Frequently asked questions about Letellier Pharma
What is the revenue of Letellier Pharma?
Letellier Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Letellier Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0554748443 for Letellier Pharma, if the company is VAT-registered. Its company number (CBE) is 0554.748.443.
Where is the registered office of Letellier Pharma?
According to the CBE register, the registered office of Letellier Pharma is in 3080 Tervuren.
What is the equity of Letellier Pharma?
At the close of the 2025 financial year, the equity of Letellier Pharma amounts to 1,491,334 €, a solvency of 49.0% of total assets.
Who manages Letellier Pharma?
The register lists 1 active mandates at Letellier Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is Letellier Pharma within its sector?
By total assets for 2025, Letellier Pharma ranks among the 5,000 largest of the 50,410 companies in its sector (NACE 7020) in Belgium that filed accounts for that financial year.
The full file of Letellier Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →